Stockscreener 앱 받기
0.5766
3.85%
-0.0234
전일 마감가:
$0.60
열려 있는:
$0.58
하루 거래량:
2.37M
Relative Volume:
2.85
시가총액:
$49.81M
수익:
$2.24M
순이익/손실:
$-136.67M
주가수익비율:
-0.2518
EPS:
-2.29
순현금흐름:
$-102.08M
1주 성능:
-6.92%
1개월 성능:
+12.39%
6개월 성능:
+4.89%
1년 성능:
-54.21%
1일 변동 폭
$0.5704
$0.65
1주일 범위
$0.552
$0.65
52주 변동 폭
$0.3418
$1.83
Century Therapeutics Inc Stock (IPSC) Company Profile
명칭
Century Therapeutics Inc
전화
215-981-4000
주소
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
IPSC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.5766 | 51.83M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.04 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.25 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.36 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.00 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.91 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-08 | 개시 | Rodman & Renshaw | Buy |
| 2023-08-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-27 | 개시 | Chardan Capital Markets | Buy |
| 2022-10-31 | 개시 | Guggenheim | Buy |
| 2022-10-10 | 개시 | Canaccord Genuity | Buy |
| 2022-05-23 | 개시 | H.C. Wainwright | Buy |
| 2022-05-12 | 개시 | William Blair | Mkt Perform |
| 2021-07-13 | 개시 | BofA Securities | Buy |
| 2021-07-13 | 개시 | JP Morgan | Overweight |
| 2021-07-13 | 개시 | Piper Sandler | Overweight |
모두보기
Century Therapeutics Inc 주식(IPSC)의 최신 뉴스
It is Poised to be a Bull Market for Century Therapeutics Inc (IPSC) - setenews.com
What machine learning models say about Century Therapeutics Inc.Trade Analysis Summary & Smart Money Movement Tracker - newser.com
What does recent volatility data suggest for Century Therapeutics Inc.Market Growth Report & Fast Moving Stock Trade Plans - newser.com
Century Therapeutics Inc. stock momentum explained2025 Pullback Review & Free Growth Oriented Trading Recommendations - newser.com
Century Therapeutics Inc. stock trendline breakdownMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com
What Fibonacci levels say about Century Therapeutics Inc. reboundMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com
How Century Therapeutics Inc. stock performs in rising dollar environmentShort Setup & Capital Efficiency Focused Strategies - newser.com
Century Therapeutics Inc. stock trend outlook and recovery pathTrade Ideas & Stepwise Trade Signal Implementation - newser.com
Analyzing drawdowns of Century Therapeutics Inc. with statistical toolsPortfolio Gains Summary & Expert Curated Trade Setups - newser.com
Real time pattern detection on Century Therapeutics Inc. stockMarket Risk Report & Short-Term High Return Ideas - newser.com
Custom strategy builders for tracking Century Therapeutics Inc.Market Weekly Review & Weekly Stock Performance Updates - newser.com
Published on: 2025-11-03 01:13:25 - newser.com
How to manage a losing position in Century Therapeutics Inc.Quarterly Growth Report & AI Driven Stock Reports - newser.com
How Century Therapeutics Inc. stock compares to industry benchmarksPortfolio Return Summary & Short-Term Trading Alerts - newser.com
What Macro Risks Could Undermine Mach Conferences and Events Limiteds ForecastCurrency Fluctuation Impact & Small Investment Growth Plans - earlytimes.in
Does Century Therapeutics Inc. show high probability of reboundEarnings Recap Report & Weekly Watchlist for Consistent Profits - newser.com
Visual analytics tools that track Century Therapeutics Inc. performanceInsider Buying & Short-Term Trading Alerts - newser.com
Can volume confirm reversal in Century Therapeutics Inc.2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Published on: 2025-11-01 08:35:05 - newser.com
Century Therapeutics Inc. stock volume spike explained2025 Market WrapUp & Safe Capital Preservation Plans - newser.com
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Decreases By 74.9% - MarketBeat
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Century Therapeutics Inc (IPSC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):